Breaking News on Contract Research, Manufacturing & Clinical Trials

Product news > Bulk ingredients

Latest news headlines

Products

Suppliers

Almac to add HPAPI capacity to retain customers’ projects into late phase development

24-Oct-2011 - Almac hopes adding high potency API manufacturing capacity at its plant in Craigavon, Northern Ireland will help it retain early phase projects as they move to late-stage development.

Abbott likely to retain CMO biz after split

20-Oct-2011 - Abbott says its contract manufacturing business is likely to be part of the diversified drug company formed after its planned corporate split.

News in brief

DPT launches $14m manufacturing investment round

13-Oct-2011 - DPT Laboratories has announced a multi- million dollar investment designed to boost its liquid and semi-solids and sterile manufacturing capacity.

Execs the winners after tax holiday, Senate report says

13-Oct-2011 - A Senate report has slammed the ACRO-backed overseas profit tax break for doing more to help execs’ pay packets than US employment.

AWAC, RecipharmCobra Biologics and O2h rebrand

13-Oct-2011 - Rebranding seems to be in vougue in the pharmaceutical services sector this month, with three firms changing their monikers.

Solvias and RohnerChem team on API development and manufacturing

05-Oct-2011 - Solvias and RohnerChem have set up a research and manufacturing services partnership designed to accelerate the production, scale-up and commercialisation of APIs.

Aesica plans expansion in US & Asia after investment

03-Oct-2011 - CDMO Aesica is to add manufacturing capacity in Asia and the US following a cash injection from private equity firm Silverfleet Capital.

News in brief

J&J hunting for new CMO for Doxil

28-Sep-2011 - Supplies of Johnson & Johnson’s Doxil cancer drug will be cut down in coming months as the company transitions to a new manufacturer.

CMLE OKed to start commercial API production at Netherlands plant

27-Sep-2011 - Cambridge Major Laboratories Europe (CMLE) is set to start commercial API manufacturing at its facility in the Netherlands after approval by Dutch regulators.

AAIPharma adds online raw material testing system

22-Sep-2011 - AAIPharma Services has created a 24/7 online quote generation and sample submission service to simplify raw material testing requests.

News in brief

Amrutanjan to bolt CMO services on to fine chemicals unit

21-Sep-2011 - Amrutanjan Health Care plans to add contract manufacturing and custom synthesis to services offered by loss making fine chemicals business, according to various reports.

Catalent and Toyobo team up to launch GPEx in Japan

21-Sep-2011 - Catalent has struck up a deal with Toyobo Biologics to launch its cell line engineering technology on the Japanese market.

Exclusive interview

New growth strategy and supply chain management system in place for SAFC, says president Gilles Cottier

19-Sep-2011 - SAFC announced its new aggressive growth strategy, including plans to expand in the developing markets, at its conference in Irvine, Glasgow last week.

Lonza MA plant sent FDA GMP warning letter about Eisai API

14-Sep-2011 - The FDA has sent a warning letter to Lonza’s Hopkinton, MA plant after inspectors found faults with how it produces an oncology API for Eisai.

CMC adds capacity at Denmark biologics site

13-Sep-2011 - Contract manufacturer CMC Biologics has ramped-up bioreactor capacity to meet demand for biologic drugs for Phase III clinical trials and beyond.

Aurobindo forms Russian manufacturing JV

08-Sep-2011 - Contract manufacturing organisation (CMO) Aurobindo Pharma has teamed up with Russian supplement maker OJSC Diod to establish a manufacturing joint-venture.

Brooks Labs has roller coaster IPO; targets export growth

07-Sep-2011 - Brooks Laboratories had a torrid first day on the Bombay Stock Exchange (BSE) with high volume trading taking the firm’s share price on a rollercoaster ride of highs and lows.

Toyobo to ramp up injectables CMO biz

06-Sep-2011 - Japanese CMO Toyobo says it will increase capacity for injectable drugs to secure its position as a service provider in the expanding biopharmaceutical sector.

DSM and Sinochem’s anti-infective ingredients JV gets green light

01-Sep-2011 - Royal DSM and Sinochem’s anti-infective manufacturing and distribution JV in China has been given the green light by competition authorities.

Advantar & DavosPharma ally to broaden service offering

01-Sep-2011 - Advantar Labs has allied with DavosPharma to accelerate clients’ development programmes with chemistry and analytical services.

Baxter ramps up Halle plant lyophilisation capacity, again

31-Aug-2011 - Baxter International has expanded freeze-drying capacity at its biomanufacturing facility in Halle, Germany citing growing pharmaceutical industry demand for cytotoxic contract manufacturing.

update

Granules to expand API and intermediate capacity

29-Aug-2011 - Chemicals maker Granules India says it will expand manufacturing capacity for oral solid dose (OSD) APIs and drug intermediates in a bid to better meet the needs of clients.

UPDATE

Boehringer Ingelheim's BVL plant to exit the CMO biz

22-Aug-2011 - US-based contract manufacturer Ben Venue Laboratories (BVL) is to exit the CMO industry.

CMOs in India & China look to grow international business

22-Aug-2011 - JB Chemicals and Asymchem Laboratories are expanding in response to interest in outsourcing manufacturing to India and China.

Outsourcing brings Neovacs to cusp of Ph III partnership

09-Aug-2011 - Neovacs is looking to partner for late stage development after using its outsourced model to bring multiple products to Phase II.